Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tiotropium bromide inhalation - Pulmatrix

Next Previous
X
Search
Drug Profile

Tiotropium bromide inhalation - Pulmatrix

Alternative Names: HandiHaler; PUR-0200; PUR0217a; PUR0228a; PUR0228b; PUR0228c; PUR0230c; VR 410

Latest Information Update: 21 Nov 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pulmatrix
  • Developer Pulmatrix; Viatris Inc
  • Class Antiasthmatics; Antibronchitics; Epoxy compounds; Esters; Small molecules; Thiophenes; Tropanes
  • Mechanism of Action Muscarinic M1 receptor antagonists; Muscarinic M3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Chronic obstructive pulmonary disease

Most Recent Events

  • 28 May 2021 No recent reports of development identified for phase-I development in Chronic-obstructive-pulmonary-disease(In volunteers) in Bulgaria (Inhalation, Powder)
  • 13 Jun 2018 Pharmacodynamics and safety data from a phase I trial in Chronic obstructive pulmonary disease released by Pulmatrix
  • 07 Jun 2018 Pulmatrix and Vectura plan a phase I/II study in Chronic obstructive pulmonary disease by end-2018

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top